SCHEMBL9268187

SCHEMBL9268187

CCCCCCCCCCCCCCCCCCCC(=O)OCCC(=O)O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.77
PAM P19021 2/20 0.69
DNM1 Q05193 1/20 0.62
GPR84 Q9NQS5 7/20 0.61
PPARG P37231 7/20 0.61
PPARD Q03181 7/20 0.61
PPARA Q07869 7/20 0.61
HDAC11 Q96DB2 5/20 0.61
TSHR P16473 4/20 0.61
PTPN1 P18031 3/20 0.61
ALDH1A1 P00352 2/20 0.61
TLR2 O60603 2/20 0.61
TDP1 Q9NUW8 2/20 0.61
FABP4 P15090 2/20 0.61
KMT2A Q03164 2/20 0.61
SLC22A6 Q4U2R8 1/20 0.61
SLC22A8 Q8TCC7 1/20 0.61
MEN1 O00255 1/20 0.61
ESR1 P03372 1/20 0.61
ALOX15 P16050 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9192690 1.00 DGKA (0.77) DGKAPAMDNM1GPR84PPARG
SCHEMBL3504664 1.00 DGKA (0.77) DGKAPAMDNM1GPR84PPARG
SCHEMBL9267814 1.00 DGKA (0.77) DGKAPAMDNM1GPR84PPARG
SCHEMBL9264021 1.00 DGKA (0.77) DGKAPAMDNM1GPR84PPARG
SCHEMBL11667303 1.00 DGKA (0.77) DGKAPAMDNM1GPR84PPARG
SCHEMBL3502455 1.00 DGKA (0.77) DGKAPAMDNM1GPR84PPARG
SCHEMBL16394039 0.98 DGKA (0.73) DGKAPAMDNM1GPR84PPARG
SCHEMBL7643095 0.92 DGKA (0.84) DGKAPAMDNM1GPR84PPARG
SCHEMBL4146112 0.92 DGKA (0.84) DGKAPAMDNM1GPR84PPARG
Stearic Acid SCHEMBL17600670 0.92 DGKA (0.84) DGKAPAMDNM1GPR84PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5391564-A E.g., rhizoxin-13-yl 3-methylthiopropionate; anticarcinogenic agents SANKYO COMPANY, LIMITED (JP) 1995-02-21 US disclosed
US-5352689-A Rhizoxin derivatives and their use as anti-tumor agents SANKYO COMPANY, LIMITED (JP) 1994-10-04 US disclosed
EP-0350315-B1 RHIZOXIN DERIVATES AND THEIR USE AS ANTI-TUMOR AGENTS SANKYO COMPANY LIMITED (JP) 1993-06-16 EP disclosed
EP-0350315-A1 Rhizoxin derivates and their use as anti-tumor agents SANKYO COMPANY LIMITED (JP) 1990-01-10 EP disclosed